Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): Analysis of the GeparSixto randomized clinical trial

Llop-Guevara A, Vladimirova V, Schneeweiss A, Villacampa G, Karn T, Zahm DM, Herencia-Ropero A, Jank P, Van Mackelenbergh M, Fasching P, Marme F, Stickeler E, Schem C, Dienstmann R, Florian S, Nekljudova V, Balmana J, Denkert C, Loibl S, Serra V (2021)

Publication Type: Journal article, Original article

Publication year: 2021

Journal

Annals of Oncology Elsevier

Publisher: ELSEVIER

City/Town: AMSTERDAM

Pages Range: S22-S22

Conference Proceedings Title: ANNALS OF ONCOLOGY

DOI: 10.1016/j.annonc.2021.03.016

Authors with CRIS profile

Peter Fasching Professur für Translationale Frauenheilkunde und Geburtshilfe

Involved external institutions

Charité - Universitätsmedizin Berlin DE Germany (DE) Vall d'Hebron University Hospital / Hospital Universitari Vall d'Hebron ES Spain (ES) Mammazentrum Hamburg MVZ GbR DE Germany (DE) Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg DE Germany (DE) GBG Forschungs GmbH (German Breast Group) DE Germany (DE) Universitätsklinikum Schleswig-Holstein (UKSH) DE Germany (DE) Universitätsklinikum Mannheim DE Germany (DE) Philipps-Universität Marburg DE Germany (DE) Universitätsklinikum Frankfurt am Main (KGU) DE Germany (DE) SRH Wald-Klinikum Gera DE Germany (DE) Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen DE Germany (DE)

How to cite

APA:

Llop-Guevara, A., Vladimirova, V., Schneeweiss, A., Villacampa, G., Karn, T., Zahm, D.-M.,... Serra, V. (2021). Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): Analysis of the GeparSixto randomized clinical trial. Annals of Oncology, S22-S22. https://doi.org/10.1016/j.annonc.2021.03.016

MLA:

Llop-Guevara, A., et al. "Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): Analysis of the GeparSixto randomized clinical trial." Annals of Oncology (2021): S22-S22.

BibTeX: Download